Incyte (INCY) EBITDA (2009 - 2026)
Incyte's EBITDA came in at -$684.19 million for Q3 2026, compared with $467.54 million a year earlier.
Powered by 
Analysis
Incyte (INCY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Incyte reported EBITDA of $724.95 million, down 53.9% year-over-year; for FY2025, it came in at $1.61 billion, up 967.7% from FY2024.
- Going back by year, EBITDA was $150.61 million in FY2024 (-78.6%), $703.19 million in FY2023 (+8.6%), $647.3 million in FY2022 (+0.6%) and $643.62 million in FY2021.
- The Q3 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2010.
- The fastest year-over-year change in EBITDA over five years came in Q3 2025 (growth of 177.3%), and the weakest in Q1 2023 (a decline of 66.9%).
- Business Quant data shows INCY's EBITDA at $724.37 million (Q2 2026), $324.92 million (Q1 2026) and $359.84 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -684.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -684.19 Mn |
| Jun 30, 2026 | 724.37 Mn |
| Mar 31, 2026 | 324.92 Mn |
| Dec 31, 2025 | 359.84 Mn |
| Sep 30, 2025 | 467.54 Mn |
| Jun 30, 2025 | 553.23 Mn |
| Mar 31, 2025 | 227.53 Mn |
| Dec 31, 2024 | 324.25 Mn |
| Sep 30, 2024 | 168.61 Mn |
| Jun 30, 2024 | -456.08 Mn |
| Mar 31, 2024 | 113.85 Mn |
| Dec 31, 2023 | 209.03 Mn |
| Sep 30, 2023 | 236.10 Mn |
| Jun 30, 2023 | 214.08 Mn |
| Mar 31, 2023 | 43.98 Mn |
| Dec 31, 2022 | 88.31 Mn |
| Sep 30, 2022 | 155.07 Mn |
| Jun 30, 2022 | 270.94 Mn |
| Mar 31, 2022 | 132.98 Mn |
| Dec 31, 2021 | 125.59 Mn |
API Access
Incyte EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();